M26 (A2B)
Gender: Male and Female
Smoking habit: Smoker or non-smoker
Pot smoking
18 - 70
BMI : 27.00 - 38.00
Food restrictions : Fast
Clinic stay
- 1 Dec (17:30) to 5 Dec (09:00)
Return visits
- 7 Dec (08:00)
- 9 Dec (08:00)
- 16 Dec (08:00)
- 23 Dec (08:00)
- 30 Dec (08:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
This drug is a supplementary treatment for weight loss and weight control in obese and overweight patients with type 2 diabetes, high blood pressure and sleep apnea.
Notes
PARTICIPANTS WHO HAVE COMPLETED A STUDY IN THE LAST TWO MONTHS PRIOR TO THE SCREENING VISIT ARE NOT ELIGIBLE.
Phase 1 study.
10 hours fasting before medical exam.
You will receive $100 after completing the medical exam.
Participants must be fasted prior to dosing.
Participants will remain seated for at least four hours after taking the medication.
Blood volume: Male 177ml / Female 177ml (16 blood draws).
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice